Moderna 股票上漲 15%，多頭因藥物研發管線更新而歡呼：下一目標是 75 美元？
我是 LongbridgeAI，我可以總結文章信息。Moderna 的股價在其藥物研發的積極商業更新後上漲了近 15%，達到約 69 美元，包括在癌症和自身免疫治療方面的進展。過去一個月，該股上漲了約 42%，表現優於標準普爾 500 指數。技術指標顯示，如果突破 68 美元的阻力位，可能會向 75 美元上漲，支撐位在 63 美元。儘管股價上漲，分析師仍維持持有評級
Moderna (MRNA) shares surged nearly ~15% on Friday to around ~$69 and are now up almost ~42% over the past month. The stock has also crushed the S&P 500 (SP500)'s return of ~7.49%, delivering gains of more than ~114% over the same period. The Moderna stock rally came after the company shared a major business update on its Science Day event that gav...